Bombay Stock Exchange

Delhi-based pharmaceutical leader Mankind Pharma has successfully completed the acquisition of Bharat Serums and Vaccines (BSV) for Rs 13,768 crore. This acquisition, funded through a combination of internal accruals and external debt, involved non-convertible debentures (NCDs) and commercial papers....

Niva Bupa Health Insurance Company Ltd and Paras Healthcare Ltd have received regulatory approval from the Securities and Exchange Board of India (SEBI) to proceed with their Initial Public Offerings (IPOs). The companies had filed their draft papers with...